Macquarie Home | Course Handbook | Library | Campus Map | Macquarie Contacts
Home page

Macquarie University ResearchOnline

Home
Add
-List Of Titles -Summary of guideline for the treatment of panic disorder and agoraphobia

Please use this identifier to cite or link to this item: http://hdl.handle.net/1959.14/80465

OpenURL Link
45 Visitors 49 Hits 0 Downloads
Title
Summary of guideline for the treatment of panic disorder and agoraphobia
Related
Australasian psychiatry, Vol. 11, Issue 1, p.29-33
Publisher
Blackwell Publishing
Date
2003
FoR/RFCD Code(s)
110300 Clinical Sciences  170200 Cognitive Sciences
Author/Creator
Andrews, Gavin
Author/Creator
Oakley-Browne, Mark
Author/Creator
Castle, David
Author/Creator
Judd, Fiona
Author/Creator
Baillie, Andrew
Description
Objective: To provide a summary of the Royal Australian and New Zealand College of Psychiatrists (RANZCP) Clinical Practice Guideline for the treatment of panic disorder and agoraphobia Conclusions: Evidence-based treatments for panic disorder and agoraphobia are now clear. These conditions are chronic and disabling in nature, are complicated by delayed treatment and the presence of other psychiatric conditions, and the presence of severe agoraphobia is a negative prognostic indicator. Choice of therapy will depend on the skill of the therapist in applying psychological treatments as well as the preferences of the patient, but there is a role for both psychological and evidence-based pharmacological approaches. The present article is a summary version of the comprehensive Clinical Practice Guideline (Australian and New Zealand Journal of Psychiatry, 2003) which was developed in accordance with National Health and Medical Research Council (NHMRC) criteria. It provides a two-page desk-top summary for use in clinical practice. Economic evaluation of the available evidence-based treatments showed that at 1 year the cost of cognitive behaviour therapy (CBT) is less than the cost of the average drug therapy (CBT becomes cheaper than paroxetine at 8 months, than clomipramine at 11 months and cheaper than imipramine at 13 months). During the second and subsequent years the superiority of CBT increases whether or not the drugs are continued. Evidence levels for specific treatments are provided in the comprehensive guideline and placed in the context of overall principles of thorough assessment and quality clinical management.
Description
5 page(s)
Subject Keyword
110300 Clinical Sciences
Subject Keyword
170200 Cognitive Sciences
Subject Keyword
agoraphobia
Subject Keyword
Clinical Practice Guidelines
Subject Keyword
panic disorder
Subject Keyword
Royal Australian and New Zealand College of Psychiatrists
Resource Type
journal article
Organisation
Macquarie University. Dept. of Psychology

Identifier
http://hdl.handle.net/1959.14/80465
Identifier
ISSN:1039-8562
Identifier
mq-rm-2003018938
Language
eng
Reviewed
Reviewed
Save/E-mail Citation
Citation Format
E-mail Address
Subject
"Australasian psychiatry"
 
OR
  • Show All  
  • Show My Selections 
Advanced Search

Search

Clinical Practice Guidelines
Andrews, Gavin
110300 Clinical Sciences

Browse

  • By Title 
  • By Author/Creator 
  • By Department/Centre 
  • By Subject Keyword 
  • By Journal/Conference 
  • By FoR/RFCD codes 
  • By Resource Type 
  • By Date 

Highlights

  • Most Accessed Objects 
  • Recent Additions 
  • Pending Publications 
  • Author Profiles 

Resources

  • About ResearchOnline 
  • FAQ 
  • Open Access 
  • Open Access-FAQs 
  • Copyright 
  • Contribute 
  • Help 
  • Contact
  • Terms and Conditions 
Valid XHTML 1.0 Strict Powered by VITAL

Copyright Macquarie University | Privacy Statement | Accessibility Information

ABN 90 952 801 237 | CRICOS Provider No 00002J

Library Staff Sign In